Further, evaluation of ATXN2 as a disease modifier in patients carrying a C9orf72 expansion mutation suggests that patients with both intermediate ATXN2 repeat lengths and C9orf72 expansions are more susceptible to ALS development (van Blitterswijk et al., 2014). This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.